236 filings
Page 3 of 12
8-K
qlh6 ckgxgblmi1ru7ql
9 Mar 22
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
4:37pm
8-K
lkxq3 cobpas
16 Feb 22
Entry into a Material Definitive Agreement
4:33pm
8-K
q3qmmls6pd2 sy2
12 Jan 22
Departure of Directors or Certain Officers
12:00am
8-K
lcgud qr5
7 Jan 22
Departure of Directors or Certain Officers
4:21pm
NT 10-Q
4gjpiqpa68
15 Nov 21
Notice of late quarterly filing
1:28pm
NT 10-Q
a8sis v8t
16 Aug 21
Notice of late quarterly filing
12:00am
8-K
a1dkcj8f cm0xv4w
4 Aug 21
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
12:00am
EFFECT
f7ggv49vrr629 nkz
23 Jun 21
Notice of effectiveness
12:15am
CORRESP
ywsr5m7mo96cq9nmor4
21 Jun 21
Correspondence with SEC
12:00am
S-1/A
4mogdesn7q25rsw 660e
9 Jun 21
IPO registration (amended)
5:08pm
UPLOAD
jxm4oc
19 May 21
Letter from SEC
12:00am
NT 10-Q
2331rtub ief
14 May 21
Notice of late quarterly filing
5:26pm
S-1
p9uyu4826h5kks73dv46
14 May 21
IPO registration
5:17pm
8-K
n5uut0 8ljgyri381c
14 May 21
Entry into a Material Definitive Agreement
4:07pm